Douglas R Dixon
Overview
Explore the profile of Douglas R Dixon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avila-Ortiz G, Ambruster J, Barootchi S, Chambrone L, Chen C, Dixon D, et al.
J Periodontol
. 2022 Oct;
93(12):1763-1770.
PMID: 36279407
A biologic is a therapeutic agent with biological activity that is administered to achieve an enhanced regenerative or reparative effect. The use of biologics has progressively become a core component...
2.
Haynes A, Hall A, Luepke P, Dixon D
J Dent Educ
. 2022 Oct;
87 Suppl 1:908-910.
PMID: 36259625
No abstract available.
3.
Dixon D, Yassin A
Clin Adv Periodontics
. 2019 Dec;
10(3):123-129.
PMID: 31854127
Introduction: Little is known regarding maintaining free gingival margin stability after immediate implant placement. Therefore, we present a sequential technique incorporating a sectional connective tissue graft with an emergence tissue...
4.
Woodward Davis A, Roozen H, Dufort M, DeBerg H, Delaney M, Mair F, et al.
Sci Transl Med
. 2019 Dec;
11(521).
PMID: 31801887
CCR5 is thought to play a central role in orchestrating migration of cells in response to inflammation. CCR5 antagonists can reduce inflammatory disease processes, which has led to an increased...
5.
Dixon D, London R
Periodontol 2000
. 2019 Aug;
81(1):167-178.
PMID: 31407441
The prevalence of inflammatory conditions around dental implants is significant. Current analysis indicates that the rates for peri-mucositis and peri-implantitis may be as high as 40%-65% and 20%-47%, respectively. Over...
6.
Dixon D, Yassin A
Clin Adv Periodontics
. 2018 Mar;
7(3):115-120.
PMID: 29593936
Introduction: Little is known regarding the success, failure, or complication rates of advanced implant procedures in patients after discontinuation therapy of long-term medications for the treatment of chronic myelogenous leukemia...
7.
Yassin A, Dixon D, Oda D, London R
Clin Adv Periodontics
. 2018 Mar;
6(1):50-56.
PMID: 29593935
Introduction: Close clinical inspection for intraoral lesions in patients with leukemia that develop chronic graft-versus-host disease (cGVHD) is critical. Additionally, neoplasias developing in bone marrow transplant patients after treatment for...
8.
Dixon D, Braude D
JEMS
. 2015 Sep;
40(8):58-60.
PMID: 26403048
In airway procedures, preparation is 90% of success. For obese patients, positioning is 90% of this preparation. Other considerations include utilizing NIPPV and nasal cannula apneic oxygenation, utilizing multiple providers...
9.
Pelaez M, Susin C, Lee J, Fiorini T, Bisch F, Dixon D, et al.
J Clin Periodontol
. 2014 May;
41(8):827-36.
PMID: 24807100
Background: Application of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been associated with significant adverse events in craniofacial settings, including swelling and seroma formation. Recent work has demonstrated an inverse...
10.
Lu S, Fiorini T, Lee J, Prasad H, Buxton A, Bisch F, et al.
J Clin Periodontol
. 2013 May;
40(7):688-97.
PMID: 23627347
Background: Previous studies document the therapeutic potential of recombinant human bone morphogenetic protein-2 (rhBMP-2) in an absorbable collagen sponge (ACS) carrier for indications in the axial and appendicular skeleton. Nevertheless,...